[1]
“: REASONABLENESS IN PRESCRIPTION FOR TREATMENT OF HYPERTENSION OUTPATIENT”, YHCĐ, vol. 62, no. 2 (2021), Apr. 2021, doi: 10.52163/yhc.v62i2 (2021).54.